Clinical Trial Update: Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial Fibrillation [NA]

View source ↗

Summary

Completed clinical trial evaluating whether dapagliflozin reduces recurrence of atrial fibrillation after catheter ablation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Atrial Fibrillation | NA | Status: COMPLETED